SickKids Selects GenoLogics for an Integrated Lab and Data Management Solution
News Jan 28, 2009
GenoLogics announced that The Centre for Applied Genomics at The Hospital for Sick Children (SickKids) is deploying its lab and data management solution across multiple facilities of its genome centre.
The GenoLogics solution will be deployed for TCAG’s Microarray Analysis and Gene Expression Facility, DNA Sequencing and Synthesis Facility, Cytogenomics and Genome Resources Facility and Genetic and Statistical Analysis Facility.
“We required a single LIMS that was flexible enough to automate data capture and workflows for each service provided, while still being able to integrate billing, reporting and sample tracking across the entire operation“, said Dr. Steve Scherer, Director of The Centre for Applied Genomics. “The solution from GenoLogics was the only one with proven capabilities to integrate data across the multiple platforms we use, while also meeting our need to effectively and efficiently serve customers around the world.”
Since Geneus is designed for the needs of genomics core facilities, the lab and data management solution can be deployed to provide TCAG with immediate value. Pre-configured integrations to more than 20 of the instruments in use at TCAG means Geneus will improve data quality and workflow management for the entire operation.
TCAG is also deploying GenoLogics’ web collaboration tool, LabLink, and adaptive reporting engine in order to generate and share information with its customers.
“GenoLogics has invested considerable resources in working closely with leading instrument vendors such as Illumina, ABI and Affymetrix to ensure our informatics platform is tightly integrated with multiple instruments,” said Sal Sanci, VP of Product Management for GenoLogics. “Our capability to provide organizations such as TCAG with an end-to-end, lab and data management solution is because we are exclusively focused on serving the unique needs of life sciences research.”
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE